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PROVIDED BY ASSISTED REPRODUCTION CLINICS
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Abstract: This paper analyses the efficacy data from assisted reproduction clinics, obtained from both scientific society reports 
and from studies published in specialised journals, in order to compare them with information published by Spanish assisted 
reproduction clinics on their websites. It aims to verify whether this information matches the reality of the findings in the 
media analysed or, in contrast, differs from the aforementioned scientific evidence. Our study shows marked discrepancies 
between the evidence of existing statistical data, and figures published by most of the clinics on their websites, which could 
constitute false advertising.
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Análisis sobre la autenticidad de la publicidad sobre la eficacia de clínicas de reproducción asistida 
Resumen: Este estudio analiza los datos de eficacia de clínicas de reproducción asistida, obtenidos tanto de informes de socie-
dades científicas como de estudios publicados en revistas especializadas, para compararlos con la información publicada por 
las clínicas de reproducción asistida de España en sus sitios web. El objetivo es verificar si esta información es conforme a los 
hallados en informes y revistas o, por el contrario, difiere de la evidencia científica mencionada. Nuestro estudio demuestra 
marcadas discrepancias entre la evidencia de datos estadísticos existentes y las cifras publicadas por la mayoría de los sitios 
web de las clínicas, lo cual constituye falsa publicidad.
Palabras clave: clínicas de reproducción asistida, frecuencia de nacimientos vivos, frecuencia de embarazos, fecundación in 
vitro, inyección intracitoplásmica de espermatozoides, publicidad falsa
Análise da verdade na publicidade sobre a eficácia fornecida pelas clínicas de reprodução assistida
Resumo: Este artigo analisa os dados de eficácia de clínicas de reprodução assistida, obtidas de relatórios da sociedade científica 
e de estudos publicados em revistas especializadas, a fim de compará-los com informações publicadas por clínicas de reprodução 
assistida espanholas em seus websites. O artigo visa verificar se esta informação coincide com a realidade dos resultados en-
contrados nos meios de comunicação analisados ou, por outro lado, difere da evidência científica acima mencionada. Nosso 
estudo mostra discrepâncias entre a evidência dos dados estatísticos existentes e indicadores publicados pela maioria das clínicas 
em seus sites, que podem constituir falsa publicidade.
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citoplasmática de espermatozoide, false publicidade
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Introduction
A major tool used by assisted human reproduc-
tion clinics (AHRC) to attract clients is to show 
— through their websites — their efficacy in 
helping women who attend them to have a much-
desired child. One ethical problem that may arise, 
however, is whether this advertising is based on 
proven scientific data, for if this is not the case, 
it might be thought that the clinics were using 
“false advertising” to achieve their ends. The aim 
of this study was to evaluate this.
To this end, the pregnancy and live birth rates 
provided by various scientific associations were 
reviewed and compare with those presented by 
the aforementioned clinics on their websites and 
brochures, in order to check whether or not there 
are discrepancies between both data sources. We 
also studied the cumulative pregnancy and live 
birth rates, with particular emphasis on the lat-
ter, since the cumulative live birth rate is what 
should — in our opinion — be more consistent 
with the percentages presented by clinics regard-
ing the possibility of having a child.
Materials and methods
In this study, we looked at the pregnancy and live 
birth rates in three geographical areas using vari-
ous sources:  in Spain, for which we used Euro-
pean Society of Human Reproduction and Em-
bryology (ESHRE) and Spanish Fertility Society 
(SEF) annual reports; in Europe, for which we 
used ESHRE annual reports from 1997 to 2010; 
and globally, for which we used articles from sci-
entific journals, such as:
Human Reproduction, Reproductive Bio-
Medicine, Fertility and Sterility, The New Eng-
land Journal of Medicine, The Lancet and the Brit-
ish Journal of Obstetrics and Gynaecology. 
The information presented by Spanish AHRC to 
their clients was obtained from a review of their 
websites between 19th and 29th May, 2015.
Results
1. Pregnancy and live birth rates in Europe per 
ovarian stimulation cycle
1.1. In-vitro fertilisation
The pregnancy rate (PR) and live birth rate (LBR) 
following in-vitro fertilisation (IVF) in Europe 
between 1997 and 2010 were first determined 
based on data published by the ESHRE in 2014 
(Table 1)(1-14). The PR varied between 22.28 % 
and 29.2 %, with a mean rate of 26.41 %, while 
the LBR varied between 13.07 % and 22.4 %, 
with a mean rate of 18.81 %.
One interesting aspect of our study was to com-
pare the trend in these indices in the 14 years 
evaluated. With the exception of the 1997 LBR 
(which was 13.07 %), the other indices varied 
very little over the years, and in fact did not ex-
ceed 6.92 percentage points for the PR and 5.8 
points for the LBR (if the 1997 rate is excluded). 
It should also be highlighted that, if data from 
the last five years only is considered, the PR var-
ied by 0.7 percentage points, and the LBR by 1.8 
points. These figures show the scant improvement 
achieved in recent years in both types of indices, 
despite advances in technical procedures in the 
same time period.
1.2. Intracytoplasmic sperm injection
Making a similar assessment to the one carried 
out with IVF, it was found that when intracyto-
plasmic sperm injection (ICSI) was used (Table 
1), the PR varied between 23.37 % and 29.9 %, 
with a mean rate of 27.22 %, while the LBR var-
ied between 12.68 % and 21.10 %, with a mean 
rate of 18.31 %. 
As with IVF, the PR and LBR obtained between 
1998 and 2010 when ICSI was used had a maxi-
mum variation of between 5.1 and 4.93 percent-
age points, respectively; even if data from the 
period 2006-2010 only were considered, the PR 
decreased by 1.1 % and the LBR increased by 2.7 
%. In other words, as with IVF, both rates (PR 
and LBR) scarcely varied in the years evaluated, 
despite possible technical improvements in both 
IVF and ICSI.
 313
Acta Bioethica  2017; 23 (2): 311-325
YEAR Reference
IVF ICSI
Pregnancy rate 
(%) Live birth rate (%)
Pregnancy rate 
(%) Live birth rate (%)
1997 (1) 22.28 13.07 23.37 12.68 
1998 (2) 23.20 16.60 24.80 17.03 
1999 (3) 24.20 17.00 26.10 16.17 
2000 (4) 24.70 18.60 26.60 19.05 
2001 (5) 25.10 18.67 26.20 19.07 
2002 (6) 26.00 18.70 27.20 19.74 
2003 (7) 26.10 17.61 26.50 17.74 
2004 (8) 26.60 17.92 27.10 17.29 
2005 (9) 26.90 18.32 28.50 18.10 
2006 (10) 29.00 21.50 29.90 18.40 
2007 (11) 29.10 21.10 28.60 20.20 
2008 (12) 28.50 21.20 28.70 20.40 
2009 (13) 28.90 20.60 28.70 19.30 
2010 (14) 29.20 22.40 28.80 21.10 
Mean rate 26.41 18.81 27.22 18.31
Table 1: Pregnancy and live birth rates with IVF and ICSI in Europe from 1997 to 2010 after one 
stimulation cycle (ESHRE annual reports).
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2. Pregnancy and live birth rates in Spain
Both rates were obtained using ESHRE (14) and 
EFSEF data(15).
2.1. In-vitro fertilisation
IVF data for Spain provided by the ESHRE for 
the period 1997 to 2010 (Table 2) were first eval-
uated. The PR varied between 23.0 % and 35.0 
%, with a mean rate of 30.55 %, while the LBR 
varied between 17.4 % and 30.6 %, with a mean 
rate of 18.65 %. As can be seen, the mean PR in 
Spain (30.55 %) is notably higher than the Euro-
pean mean (27.22 %), which certainly indicates 
the technical quality of Spanish AHRC.
2.2. Intracytoplasmic sperm injection
When the same analysis was carried out for ICSI, 
the PR per ovarian stimulation cycle varied be-
tween 26.7 % and 35.4 %, with a mean of 32.5 
% (Table 2); the LBR was lower, varying between 
14.6 % and 25.6 %, with a mean of 19.4 %.
In the 14 years covered by this study, variabil-
ity for both indices was between 8.7 percentage 
points for the PR and 9.6 points for the LBR.
2.3. Data for Spain for the years 2011 and 2012
Year Reference
IVF ICSI
Pregnancy rate (%) Live birth rate (%) Pregnancy rate (%) Live birth rate (%)
1997 (1) 23.20 29.50 
1998 (2) 23.00 17.40 26.70 19.50 
1999 (3) 26.20 32.40 25.60 
2000 (4) 28.80 17.60 32.10 20.10 
2001 (5) 28.70 19.20 30.60 21.00 
2002 (6) 32.70 21.70 35.20 22.50 
2003 (7) 32.80 17.90 35.40 17.00 
2004 (8) 31.80 14.50 32.50 16.00 
2005 (9) 30.70 10.40 33.10 14.60 
2006 (10) 34.90 30.60 34.00 17.60 
2007 (11) 34.60 33.60 
2008 (12) 31.50 18.40 34.60 20.00 
2009 (13) 35.00 20.00 33.90 19.20 
2010 (14) 33.80 17.50 32.70 19.70 
Mean rate 30.55 18.65 32.59 19.40
Table 2: Pregnancy and live birth rates with IVF in Spain from 1997 to 2010 after one stimulation 
cycle (ESHRE annual reports).
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In addition to the data for Spain obtained from 
the ESHRE, the SEF also published data for 
2011 and 2012(15).
2.3.1. In-vitro fertilisation
The PRs for those years were 32.7 % (2011) and 
33.5 % (2012), while the LBRs were 17.3 % and 
19.4 %, respectively(15).
Notably, the statistics provided by the ESHRE for 
these last two years were no better than the those 
of the previous 14 — and in fact were even worse 
— clearly indicating that, as in previous years, the 
AUTHOR REFERENCES
LIVE BIRTH RATE
1 cycle % 2 cycles % 3 cycles % > 3 cycles % Overall %
Tan (18) 45.0 (a)
Engmann (19) 20.0 33.2 48.2 51.3
Stolwijk* (20) 54.5*
Kovacs (21) 20.7*
Schröder (22) 51.2*
Pellink (23) 50.5
Stern (24) 30.4 43.3 49.1 51.9 a 53.8 (b)
Gnoth (25) 52.0 85 (c)
Setti (26) 53.3 73.8 (d)
Malizia (27) 53.2
Stern (28) 62,1
Smith (29) 29.5 65.3 (e) 68.4
Ishihara (30) 28.5
Mean rate 26.6 38.3 47.4 66.0 56.3
* Data on pregnancy rate (PR), not cumulative live birth rate (CLBR). Not included in the calculation of the mean rate.
a) This rate was obtained after five stimulation cycles
b) After eight cycles 
c) After twelve cycles
d) After six cycles
e) After six cycles
Table 3: CLBR according to various authors
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efficacy of the technique did not improve in that 
time.
One fact to highlight is that in Spain, the LBRs 
are markedly lower than the PRs. We have no rea-
sonable explanation for this, although it does not 
have any bearing on our paper since it is not the 
specific aim of this study.
2.3.2. Intracytoplasmic sperm injection
When the same data were analysed for ICSI, the 
PR corresponding to those two years was 31.7 
% and 31.0%, while the LBR was 18.8 % and 
18.1%, respectively.
3. Cumulative pregnancy and live birth rates
The efficacy of assisted human reproduction tech-
niques using IVF and ICSI has until now general-
ly evaluated the pregnancy and live birth rate per 
stimulation cycle. However, these rates do not ap-
pear to be the most appropriate, because when a 
couple attend an assisted procreation clinic, they 
basically want to know the likelihood of having a 
child after one or several stimulation cycles. This 
technically corresponds to the cumulative live 
birth rate (CLBR). 
The cumulative pregnancy rate (CPR) can also be 
used, i.e. the likelihood, expressed in percentage, 
that a woman will become pregnant following 
several stimulation cycles. However, since obvi-
ously not all pregnancies go full term, ending 
with the birth of a child, we consider the CLBR 
to be the most appropriate index for evaluating 
the efficacy of these methods.
To that end, we evaluated the CLBR obtained 
in various studies and under different circum-
stances, such as the woman’s age, whether fresh 
or frozen oocytes were used, whether these were 
autologous or donor oocytes, cause of the infertil-
ity and other circumstances. 
As shown in Table 3, several studies that provided 
objective data on the CLBR were conducted since 
the beginning of the 1990s. Several of these found 
that the woman’s age decisively affected the rates 
when autologous oocytes are used. Other studies 
not included in this Table confirm this(16,17).
We believe that these should be taken into con-
sideration, since increasingly older women are 
now attending AHRCs to have a child. Accord-
ingly, the CPR and CLBR obtained in women 
over 38 years could be more relevant to the stan-
dard practice of these techniques.
In 2010, Gelbaya performed a systematic review 
and meta-analysis that evaluated the CLBR in re-
lation to whether one or two embryos had been 
transferred(31), finding that, in a study by Thurin 
et al.(32), the CPR after three stimulation cycles 
was 38.8 % when one embryo was transferred, 
and 42.9 % when two embryos were transferred. 
Lukassen et al.  obtained rates of 40.7 % and 
38.5 % respectfully(33), while Moustafa et al. 
found rates of 45.0 % and 46.3 %(34). A study 
by Heijnen found rates of 43.4 % and 44.7 %, 
respectively, in women who had received up to a 
maximum of four treatment cycles, after moder-
ate ovarian stimulation(35). In other words, until 
2010, the overall CPRs and CLBRs continued to 
hover around 50 %.
Another large study continued to show that when 
autologous oocytes were used, the CLBR de-
creased with the woman’s age. Thus, the CLBR 
obtained after three stimulation cycles was 63.3 
% for women under 31 years, 18.6 % for those 
aged between 41 and 42 years, and 6.6 % for those 
aged 43 years or older(36).  When donor oocytes 
were used, the overall CLBR varied between 50 
% and 55 %, i.e. very similar to that obtained in 
previous studies. However, in addition to the spe-
cific outcomes mentioned, it should be highlight-
ed that in this last study, the authors used data 
provided by the Society for Assisted Reproduc-
tive Technology Clinic Outcome Reporting Sys-
tem, which collected information between 2004 
and 2009 from more than 90 % of AHRC in the 
United States. The number of women evaluated 
was therefore very high (246,740), as was the 
number of live births (140,859). It should also be 
noted that these data were verified by the Centers 
for Disease Control and Prevention (CDC) and 
the Fertility Clinic Success Rate and Certification 
Act, which attests to their validity.
Also in 2013, Stern et al. again studied the CLBR 
in relation to the cause of the infertility that led 
the patient to consult the AHRC, making spe-
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cial reference to diminished ovarian reserve. They 
found that in women with diminished reserve, 
the CLBR was only 28.3 %, but that other causes 
of infertility barely affected this rate, which in this 
group of women was 62.1 %(28).
In 2015, one study found that no age-dependent 
differences were observed when donor oocytes 
were used(29).
In our view though, the most complete informa-
tion on CLBR (following IVF or ICSI) undoubt-
edly comes from a report by the International 
Committee for Monitoring Assisted Reproduc-
tive Technologies: World Report on Assisted 
Reproductive Technologies(30), which included 
1,251,881 assisted reproduction interventions, 
collecting data from 2419 clinics in 55 countries. 
Although the Report was published in February 
2015, the data evaluated correspond to 2007.
The most important point in the study by Ishi-
hara et al. is that the overall CLBR was 28.5 %; 
this is the percentage that expresses, among all the 
clinics evaluated, the likelihood that a woman can 
have the desired child.
These rates naturally vary significantly among 
countries, the highest being found in the United 
States (41.8 %) and the lowest in Bosnia-Herze-
govina (12.7 %).
Obviously, we cannot go into detail here on the 
CLBRs in the 55 countries included in the study, 
but those with the largest economic development 
are clearly those with the highest CLBR (Table 4).
Aside from the data on individual countries indi-
cated here, it is interesting to highlight the CLBR 
by continental groups, which in Europe was 24.6 
%, in Asia 17.8 %, in Australia and New Zealand 
30.8 %, in Latin America 26.0 %, and in North 
America 40.8 %; the global overall CLBR, as pre-
viously mentioned, was 28.5 %.
4. Outcomes provided by Spanish assisted human 
reproduction clinics regarding the likelihood that 
a woman attending them will have a child
When evaluating AHRCs in Spain, it is interest-
ing to differentiate between public and private 
clinics. In order to elicit the outcomes provided 
by AHRCs on their websites, 169 web pages were 
analysed; this represents 278 clinics, 27.22 % of 
which were public, while 72.78 % were private.
Outcomes provided by public AHRCs
Of the 46 Spanish public clinics that offer as-
sisted human reproductive techniques, we were 
able to obtain success rates for only three. The 
most reliable statistics were presented by Hospi-
tal Universitario Virgen de las Nieves, Granada, 
with a PR following IVF of 32.8 % in 2014 (37). 
The mean PR in the three clinics was 35.3 %. 
Remarkably, although all of these public clinics 
have participated in the SEF data register in re-
cent years, none have publically reported their 
success rates.
COUNTRY CLBR ( %)
Spain 22.9
Belgium 26.2
Denmark 24.7
Sweden 31.8
Norway 31.3
France 23.7
Germany 20.1
Italy 18.3
Holland 26.7
Poland 36.5
Russia 24.7
United Kingdom 31.6
Canada 38.1
United States 41.8
Table 4: CLBR in several developed countries 
2007(30).
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Outcomes provided by private AHRCs
The data obtained from private AHRCs are very 
different. Of the 123 private clinics that we ana-
lysed, 48.78 % published some information on 
their PRs, but interestingly, none published in-
formation on the rate per cycle or CLBR, which 
is very surprising.
All the information is shown in Table 5, where 
it can be seen that, as regards the private clinics, 
the CPR with autologous oocytes following one 
1 2 3 4 5
PRIVATE AHRC Overall(%)
<35
years (%)
35-39 years 
(%)
≥40 
years (%) (%) (%) (%) (%)
Barcelona IVF       (http://www.
barcelonaivf.com) X
Embriogyn (http://www.embriogyn.
com) 52.0 63.7
Ginefiv  
(http://www.ginefiv.com) 60.0 50.0 35.0 60.0 85.0 X
CEFIVBA 
(http://www.cefivba.com) 37.7 44.4 X
ProcreaTec  (http://www.procreatec.
com) 50.0 32.0 18.0 69.0 90.0
Grupo Hospitalario Quirón  (http://
www.quiron.es) 28.0
FIV CENTER (http://www.
fivcenter.com) 50.0 52.0 46.0 33.0
Gravida. Fertilitat Avançada    
(http://www.gravidabcn.com) 49.2 70.4 43.7 34.2 71.0
Institut Conceptum (http://www.
conceptum.es) 49.0 90.0 X
FecunMed  (http://www.fecunmed.
com) 49.6 63.6 41.2 34.8 58.0
Instituto Murciano de Fertilidad 
(IMFER)(http://www.imfer.com) 53.0 39.0 26.0 57.0 90.0 X
Clínica Sanabria 
(http://www.clinicasanabria.com) 50.0 20.0
Clínica IMF Madrid 
(http://www.imfertilidad.com) 52.0 62.0 47.0 31.0 90.0 X X
Biogest  
(http://www.biogest.es) 40.0
HM Fertility Center  (http://www.
hmfertilitycenter.com) 60.0 90.0 X
Instituto Bernabeu  (http://www.
institutobernabeu.com) 79.9 72.0 48.6 84.5 95.0 X
Clínica Mencia (http://www.
clinicamencia.com) 45.0 80.0
Grupo Hospitalario Quirón 
(Barcelona)  (http://www.barcelona-
reproduccion.quiron.es)
50.0 56.0 40.3 21.3 68.0
TAHE Fertilidad (http://www.
tahefertilidad.es) 45.0 40.0 32.0 58.0
Table 5: Information presented by the websites of Spanish private AHRCs.
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1 2 3 4 5
PRIVATE AHRC Overall(%)
<35
years (%)
35-39 years 
(%)
≥40 
years (%) (%) (%) (%) (%)
FIV VALENCIA  
(http://www.fiv-valencia.es) 47.0 60.0 90.0 X
Clínica Tambre  
(http://wwwclinicatambre.com) 52.5 44.2 33.8 65.0
CREA  
(http://www.creavalencia.com) 50.8 45.3 68.4
URE Centro Gutenberg  (http://
www.urecentrogutenberg.es) 57.0  % 49.0 37.0 75.0
Girexx  
(http://www.girexx.es) 48.0 48.0 34.0 34.0 58.0
Institut Marquès  (http://www.
institutomarques.com) 72.2 82.4 77.8 41.1 63.2
Clínica Montpellier  (http://www.
clinicamontpellier.com) 35.0 50.0 80.0
Instituto para el Estudio 
de la Esterilidad  (http://
wwwestudioesterilidad.com)
60.0 80.0
Unidad de Fertilidad de Almoradí-
Alicante (UFEAL)  
(http://www.ufeal.com)
40.0
CEFIVA Centro de Fertilización In 
Vitro de Asturias  (http://www.cefiva.
com)/es/
36.8 55.0 42.4 23.4
Unidad de Reproducción Clínica 
Vistahermosa  (http://www.
urvistahermosa.com)/es/
60.0 70.0 80.0 X
Clínica Medrano (http://www.
clinicamedrano.com)/ 40.0
Centro Ginecológico Bolonia (http://
www.ginecologiabolonia.es)/
IRAGA UR Asistida La Rosaleda 
(http://www.iraga.net/es/ 45.0 90.0
Clínica Eugin  
(https://http://www.eugin.es)/ 71.0 52.0 37.0 65.0
AisaFiv  
(http://www.aisafiv.com)/ 48.6 55.0 50.0 33.3 66.7
CARE Clínica Ginecológica  (http://
www.careclinica.es)/ 45.0 60.0
IVI  
(http://www.ivi.es)/ 53.6 63.9 54.4 45.0 68.9 90.0 X
Centro Ginecológico de León  
(http://www.centrogine.es)/ 45.0
CER Santander  
(http://www.cersantander.com)/ 50.0 33.3
UltraFiv-Bahía  (http://www.
ultrafivbahia.com)/ 46.4 62.3
Clínica Imar 
(http://www.clinicaimar.com)/ 60.0 56.0 31.0 80.0
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1 2 3 4 5
PRIVATE AHRC Overall(%)
<35
years (%)
35-39 years 
(%)
≥40 
years (%) (%) (%) (%) (%)
CERAM -Centro de RA de Marbella  
(http://www.ceram.es)/ 67.0 70.0
Clínica Fertia        (http://www.
clinicafertia.com)/ 50.0 75.0 29.0 12.0 60.0 X
FertiMed             (http://www.
fertimed.info/index.php/es/ 60.0
Invitam   
(http://www.invitam.es)/ 50.0 70.0 70.0 85.7
Instituto Canario de Infertilidad 
(ICI)  (http://www.icinfertilidad.
com)/
44.8 57.6
Clínica Rubal  
(http://www.rubal.es)/ 40.8 46.1 64.0
URH García del Real
(http://www.urh.es)/ 43.0 57.0 38.0 19.0 61.0 83.0 X
Instituto de Fertilidad (IF) (http://
www.institutodefertilidad.es)/ 51.0 98.0
Instituto de Fertilidad Rincón  
(http://www.fertilidad.clinicasrincon.
com)/
45.0 52.0 47.0 64.0
FIV Madrid  
(http://www.fivmadrid.es)/ 62.0 50.0 34.0 82.0 X
Másvida Reproducción 
(http://www.masvidareproduccion.
com)/
49.2 59.1 47.1 24.2 64.9
Clínica Norba            (http://www.
clinicanorba.com)/ 50.0
Fertilab   
(http://www.fertilab.com)/ X
Centro de infertilidad - Doctora 
Irene Matarranz (http://www.
doctorairenematarranz.com)/
35.0 70.0
Roquetas FIV (http://www.
roquetasfiv.com)/wordpress/ 33.9 80.0
FIV Barcelona   (http://www.
fivbarcelona.org/ 50.0
Unitat Endocrinologia Ginecològica 
(Ueg)         (http://www.uegclinic.
cat/
55.3 75.2 85.0
F. Puigvert-Hospital de la Santa Cruz 
y San Pablo  (http://www.fundacio-
puigvert.es)/
47.0
FIV Clínic 
(http://www.hospitalclinic.org/ 45.6
Institut Dexeus   
(http://www.dexeus.com)/ 45.0 55.0 25.0 60.0 80.0
Àptima Centre Clínic MútuaTerrassa 
(http://www.aptimacentreclinic.
com)/
50.0
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1 2 3 4 5
PRIVATE AHRC Overall(%)
<35
years (%)
35-39 years 
(%)
≥40 
years (%) (%) (%) (%) (%)
Clínica Ruber Internacional 
(http://www.unidaddelamujer.es)/
ginecologia/ginecologia/#
60.0 70.0
Hospital Universitario Sanitas La 
Zarzuela (http://www.sanitas.es)/
sanitas/seguros/es/particulares/
medicosycentros/hospital_zarzuela/
index.html
X
Instituto Europeo de Fertilidad 
(http://www.iefertilidad.com)/ 84.9 X
IBILAB (Instituto Balear de 
Infertilidad)                 (http://www.
ibi-es.com)/
46.0 74.0
Centro de Asistencia a la RH de 
Canarias (FIVAP) (http://www.fivap.
com)/
40.0 62.0
Ginemed  
(https://http://www.ginemed.es)/ 44.9 61.8 83.0
Centro Médico Teknon (http://www.
teknon.es)/web/reproduccion-asistida 40.0 39.0 27.0 15.0
Mean rate 47.2 59.0 47.4 30.7 65.0 85.3
Notes:
1: Pregnancy rate per stimulation cycle with autologous oocytes
2: Pregnancy rate per stimulation cycle with donor oocytes
3: Cumulative pregnancy rate.
4: Guarantee that the patient can become pregnant and have a child
5: Can resolve all infertility issues
Note: A total of 169 websites representing 278 AHRCs were reviewed, 232 of which were private and 
46 public. Only those clinics that provide information on any of the indices shown in the table are 
listed. Data consulted between 19th and 29th May, 2015.
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the CLBR. Accordingly, it is this rate on which 
most emphasis will be placed in this study.
Pregnancy and live birth rate per cycle of IVF 
or ICSI
If we consider European data (Table 1), the mean 
PR obtained using IVF after one stimulation cy-
cle is 26.41 %, with a LBR of 18.81 %. The latter 
is the most significant, since in reality it is the one 
that translates into the likelihood that a European 
woman has of achieving a live birth after a single 
stimulation cycle. 
When the number of live births using ICSI was 
evaluated (also after one stimulation cycle) (Table 
1), the mean PR was 27.22 % and the LBR was 
18.31 %.
When we looked at ESHRE data for IVF in Spain 
for the 14 years between 1997 and 2010 (Table 
2), the PR after a single stimulation cycle was 
found to range between 23.2 % and 35.0 %, with 
a mean of 30.55 %, while the CLBR, also after 
a single stimulation cycle, ranged between 10.4 
% and 30.6 %, with a mean rate of 18.65 %. As 
already mentioned, though, the LBR per stimula-
tion cycle is not the same as the outcomes provid-
ed by the clinics for the likelihood that a woman 
will have a child (since this may be achieved after 
three or more stimulation cycles), but it is a figure 
that brings us closer to that reality.
Nevertheless, in relation thereto, if the likelihood 
of having a child following one stimulation cycle 
is, for example, 35 %, one might think that af-
ter three stimulation cycles, this likelihood could 
reach or exceed 75 %. However, this is not ap-
parent in reality, because as mentioned earlier, 
as the number of stimulation cycles increases, 
the number of live births achieved after the first, 
second and third (or even more) cycles increases 
very little with respect to that achieved in the first 
cycle(24).  We therefore consider that the index 
that provides information closest to reality is the 
LBR after three stimulation cycles. Moreover, this 
is the practice generally followed in most clinics. 
In this respect, according to SEF data, the CLBR 
in Spanish AHRC after three stimulation cycles 
rarely exceeds 50 %(15).
stimulation cycle varies between 28 % and 72.2 
%, with a mean rate of 47.2 %.
These rates for women under 35 years range from 
39.0 % to 82.4 %, with a mean rate of 59.0 %; 
for those aged 35 to 39 years, they range from 
27.0 % to 77.8 %, with a mean rate of 47.4 %; 
and for those older than 40 years, the rates range 
from 12.0 % to 48.6 %, with a mean rate of 30.7 
%.
When donor oocytes are used, the rates — as can 
be seen in Table 5 — are better, with a mean of 
65.0 %, as would be expected when the woman’s 
age does not affect the outcomes. What is surpris-
ing though is the high CPR, which ranges from 
75 % to 98 %, with a mean of 85.3 %.
All these data are those presented explicitly by the 
AHRCs on their websites. In our opinion, how-
ever, the most startling claims are those that make 
reference to comments or statements that could 
be labelled as more commercial. Here, we refer to 
statements from those clinics that guarantee that 
the couple will have a child (Table 5, column 4), 
i.e. that they are 100 % effective, and other com-
ments stating that they can provide solutions to 
any infertility issues (Table 5, column 5).
Discussion
To compare the success rates that private AHRCs 
in Spain claim on their websites and brochures 
with the data that these same clinics provide to 
the different scientific entities and professional as-
sociations, we carried out three types of analysis. 
Firstly, we evaluated the PR and LBR per stimu-
lation cycle following IVF or ICSI for Spain and 
Europe, from data provided by scientific associa-
tions such as the SEF and ESHRE. Secondly, we 
obtained the cumulative data for these same rates 
in Spain, Europe and the rest of the world; and 
thirdly, we reviewed the outcomes that Spanish 
AHRCs profess to their clients on their websites 
and brochures, with special emphasis on their 
success rates, i.e. the likelihood that women at-
tending them will have a child, since this is the 
main reason for attracting clients (offering them 
a high probability of having a child). In our opin-
ion, technically, this success rate is equivalent to 
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When donor oocytes are used, the rates were 
higher, varying between 44.4 % and 85.7 %, with 
a mean rate of 65.0 %. The mean CPR will be 
higher than the mean LBR, as this is what usually 
occurs, as can be seen in the ESHRE data shown 
in Tables 1 and 2.  
It is particularly striking that the CLBR is not 
publicised by any of the private clinics reviewed. 
It should also be highlighted that the overall PR 
reported by these private clinics on their websites 
for one stimulation cycle ranges between 28.0 % 
and 72.2 %, with a mean value of 47.2 % when 
autologous oocytes are used, and 65.0 % when 
donor oocytes are used (Table 5). When this rate 
-for the same clinics- was evaluated from SEF 
data, the PR was 30.55 % for IVF and 32.59 % 
for ICSI (Table 2), meaning that the mean ef-
ficacy outcomes reported on the websites of the 
Spanish AHRC analysed are 49.5 % higher than 
those of the SEF and ESHRE in one stimulation 
cycle with autologous oocytes, and up to 108.9 % 
higher when donor oocytes are used.
This finding certainly supports our thesis that 
many Spanish AHRC present statistics on their 
websites that are very far removed from those pro-
vided by official sources.
Another notable aspect is that 16 of these clin-
ics expressly state on their websites and brochures 
that they guarantee that women attending them 
will become pregnant, which would mean a 100 
% success rate.
It should also be highlighted that some of these 
clinics state that they can resolve all their clients’ 
fertility issues, and at the same time have been 
audited by companies or institutions of proven 
good standing. Finally, many of them also state 
that they use the most advanced technology.
Conclusion
Many Spanish AHRCs present data on their web-
sites that are not consistent with those obtained 
from official ESRHE or SEF reports. This is first 
of all because they do not report data on live 
births, which is the rate that best matches the real 
likelihood that assisted reproduction treatments 
When the data obtained using ICSI were evalu-
ated, the outcomes were very similar to those 
achieved with IVF (Table 2). 
When data for Spain were analysed using the 
information provided by the SEF, the outcomes 
were akin to those in the EHSRE reports, and as 
such very similar comments can be made in both 
cases.
Most interestingly with respect to Spain, we 
found that in the last years analysed (2011 and 
2012), neither rate varied much (and in fact they 
even fell), meaning that the efficacy of the tech-
niques has not improved recently(15).
Outcomes using ICSI were very similar to those 
for IVF, so the comments are equally applicable.
Cumulative live birth rates
The CLBRs (Tables 3 and 4), together with evalu-
ation of the data provided on the AHRC websites 
(Table 5), are of particular interest, since these 
rates are the ones that will undoubtedly translate 
into the real likelihood that a woman attending a 
AHRC will have a child; moreover, the latter are 
the figures that clinic websites show their poten-
tial clients.
Although there is a large variation in the CLBR of 
the different countries for which data are present-
ed in the study by Ishihara et al.(30)  — ranging 
from 18.3 % for Italy to 41.8 % for the United 
States — the figures in Table 3 (which provides 
data from 13 different studies) show an overall 
mean LBR of 56.3 %, if outcomes from the four 
studies that provide this information are includ-
ed. This value is much higher than the percent-
age obtained for Spain, with 22.9 % in one of 
the studies(30), and 18.65 % (IVF) and 19.40 
% (ICSI) according to the ESHRE, as the mean 
value for the period 1997-2010 (Table 2).
Data provided by Spanish AHRC on their web-
sites
A total of 169 websites were evaluated out of a 
total of 278 AHRC (232 private and 46 public 
clinics). Table 5 includes the PR per stimulation 
cycle when autologous oocytes were used, and 
ranges between 28 % and 72.2 %, with an overall 
mean rate of 47.2 %.
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Statements guaranteeing that 90 % of women 
will reach their objective of having a child are 
particularly noteworthy. This, in our opinion, can 
constitute false advertising, something that merits 
a very negative ethical rating.
will eventually lead to the goal of parenthood. 
This, of course, is what clients seek in these clin-
ics. With respect to the PR published by Spanish 
AHRCs on their websites, the data differ openly 
from those reported by the ESHRE and SEF, 
professing mean efficacy outcomes 49.5 % higher 
than official reports in a stimulation cycle with 
autologous oocytes, and up to 108.9 % higher 
when donor oocytes are used.
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